This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Diabetic polyneuropathy and risk of developing diabetic retinopathy

Diabetic polyneuropathy and risk of developing diabetic retinopathy
Reviewed by Bheemanagouda Patil

1 February 2016 | Bheemanagouda Patil | EYE - Vitreo-Retinal

Diabetic polyneuropathy (DPN), diabetic retinopathy (DR) and diabetic nephropathy are widely classified as microvascular complications of diabetes. DPN, which may cause complete sensation loss, is another common complication of DM. The DPN-related diminished sensation presents a significant risk factor for subsequent diabetic ulcers and non-traumatic amputations. The prevalence rate of diabetic neuropathic pain is approximately 10-20% among the diabetic population, and approximately 40-60% in patients with documented neuropathy. The purpose of this study was to assess the relationship between DPN and the risk of DR. From 1997 to 2010, 5031 newly diagnosed DPN patients and 20,124 controls matched for sex, age and index year, were identified. The adjusted hazard ratio was calculated and adjusted for age, sex, duration of diabetes and comorbidities of hypertension, cardiovascular disease and diabetic nephropathy. The incidence rate of DR was 5.87-fold higher in the DPN patients than in the non-DPN group, with an adjusted HR of 5.41 (95% CI = 4.92–5.94). The DPN-to-non-DPN DR incidence rate ratio decreased with age. Compared with the non-DPN group, the DPN patients had a 5.63-fold risk of non-proliferative DR and a 3.67- fold risk of proliferative DR. 

Diabetic polyneuropathy and the risk of developing diabetic retinopathy: a nation-wide, population-based study.
Lin IC, Wang YH, Lin CL, et al.
ACTA OPHTHALMOLOGICA
2015;93:713-8.
Share This
CONTRIBUTOR
Bheemanagouda Patil

Waikato Hospital, Hamilton, New Zealand

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency